REMI - Remedent, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1400
-0.0180 (-11.39%)
At close: 3:23PM EDT
Stock chart is not supported by your current browser
Previous Close0.1580
Open0.1400
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1200 - 0.1400
52 Week Range0.1000 - 0.2000
Volume75,000
Avg. Volume582
Market Cap2.799M
Beta (5Y Monthly)-0.28
PE Ratio (TTM)1.36
EPS (TTM)0.1030
Earnings DateNov 10, 2019 - Nov 13, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.50
  • Remedent Inc. strengthened its participation in the global dental venture of tomorrow Metrics in Balance NV
    GlobeNewswire

    Remedent Inc. strengthened its participation in the global dental venture of tomorrow Metrics in Balance NV

    On March 29th, 2019 Remedent Inc. (OTCBB:REMI.OB) participated, through its 99,99% Belgian daughter company REMEDENT NV, in the contribution in kind of the Belgian company Metrics in Balance NV, stock listed on Euronext Access Paris (ISIN:BE0974328602) and having it registered office at 9000 Ghent, Zuiderlaan 1-3, box 8, Belgium (“MiB”). Metrics in Balance NV is a company developing and refining the clinical concept that allows healthcare and dental professionals to diagnose the relationship between malocclusion and posture problems. As a medical data collector MiB wishes to further strengthen its market position and invest in established and start-up companies who can create an added value for MiB or an accumulated economies of scale for the companies together.